Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01.
Entry into a Material Definitive Agreement.
Credit Agreement
On the Closing Date, in connection with the Merger,
Acuren entered into the Second Amendment to Credit Agreement (the “Second Amendment”), by and among Acuren Delaware Holdco,
Inc., a wholly-owned subsidiary of Acuren (the “Initial Borrower”), Acuren Holdings, Inc., a wholly-owned subsidiary of Acuren
(“Holdings” and, together with the Initial Borrower, the “Borrowers”), Acuren, the other Loan Parties (as defined
in the Credit Agreement referred to below) party thereto, the Amendment No. 2 Lenders (as defined therein) party thereto, and Jefferies
Finance LLC, as administrative agent (the “Administrative Agent”), which amended the Credit Agreement, dated as of July 30,
2024, by and among the Borrowers, Acuren, the other Loan Parties party thereto, the lenders from time to time party hereto, the L/C Issuers
from time to time party thereto, the Administrative Agent and Jefferies Finance LLC, as collateral agent, as amended by that certain First
Amendment to Credit Agreement, dated as of January 31, 2025, by and among Acuren, the Initial Borrower, Holdings, the other Loan Parties
party thereto, the Amendment No. 1 Term Loan Lenders (as defined therein), and the Administrative Agent (as amended, restated, supplemented,
or otherwise modified from time to time, the “Credit Agreement”).
The Second Amendment amended the Credit Agreement
to (i) include new term loans in an aggregate principal amount of $875 million (the “Amendment No. 2 Term Loans”) and (ii)
increase the aggregate amount of the senior secured revolving credit facility to $125 million. From and after the Closing Date, principal
payments on the Amendment No. 1 Term Loans (as defined in the Credit Agreement) and the Amendment No. 2 Term Loans, commencing on September
30, 2025, will be made in quarterly installments on the last day of each fiscal quarter in an amount equal to approximately $4.13 million,
subject to adjustments in accordance with the Credit Agreement. The Amendment No. 2 Term Loans, together with the Amendment No. 1 Term
Loans, will mature on July 30, 2031. The proceeds of the Amendment No. 2 Term Loans were used to finance the Merger and pay transaction
costs associated with the Second Amendment.
All other material terms of the Credit Agreement,
as amended by the Second Amendment, remained unchanged.
Relationships
Acuren and certain of its affiliates have previously
entered into commercial financial arrangements with certain of the lenders, and/or their respective affiliates, and each of these entities
and/or their affiliates has in the past provided financial, advisory, investment banking and other services to Acuren and its affiliates,
including serving (1) as a book runner and/or global coordinator for the Acuren’s initial public offering in the United Kingdom,
(2) as a lender and/or in other related capacities in connection with the Credit Agreement and the various term loans and revolving credit
facility under the Credit Agreement, (3) as financial advisor and capital markets advisor in connection with the Acuren’s acquisition
of Holdings and NV5, and (4) as lead placement agent in connection with the Acuren’s private placement.
Item 2.01Item 2.01 - Completion of Acquisition
Item 2.01.
Completion of Acquisition or Disposition of Assets.
As discussed in the Introductory
Note, which is incorporated into this Item 2.01 by reference, on the Closing Date, Acuren completed its previously announced acquisition
of NV5. As a result of the Merger, each share of common stock of NV5, par value $.01 per share (the “NV5 Common Stock”), issued
and outstanding immediately prior to the effective time of the First Merger (the “First Effective Time”), other than Excluded
Shares (as defined below) and Appraisal Shares (as defined below) was converted into the right to receive (i) 1.1523 shares of Acuren
Common Stock (the “Per-Share Share Consideration”) and (ii) cash in the amount of $10.00 (the “Per-Share Cash Consideration”
and, together with the Per-Share Share Consideration, the “Merger Consideration”). No fractional shares of Acuren Common Stock
will be issued in the First Merger, and holders of NV5 Common Stock will, instead, receive cash in lieu of fractional shares of Acuren
Common Stock, if any, as provided in the Merger Agreement.
In addition, at the First Effective Time:
(i) each share of NV5 Common Stock, that was owned by any of Acuren,
Merger Sub I, Merger Sub II or NV5 (including shares held as treasury stock or otherwise) or any of their respective subsidiaries immediately
prior to the First Effective Time (collectively, the “Excluded Shares”) was automatically cancelled and ceased to exist and
no consideration was delivered in exchange for such shares of NV5 Common Stock;
(ii) each share of NV5 Common Stock that was outstanding immediately
prior to the First Effective Time and that was held by any Person who was entitled to demand and properly demanded appraisal of such
shares of NV5 Common Stock in accordance, and who complied in all respects, with Section 262 of the Delaware General Corporation Law
(“Section 262”) (each such share, an “Appraisal Share”) was automatically cancelled and ceased to exist and each
holder of an Appraisal Share ceased to have any rights with respect thereto, except the right to appraisal of the fair value of such
Appraisal Share in accordance with Section 262;
(iii) each NV5 RSA (as defined in the Merger Agreement) that was outstanding immediately prior to the First Effective Time was assumed by Acuren
and converted into a restricted stock award relating to a number of shares of Acuren Common Stock equal to 2.0387 shares of Acuren Common
Stock per NV5 RSA, rounding to the nearest whole number of shares; and
(iv) each NV5 Executive RSA (as defined in the Merger Agreement) that was outstanding immediately prior to the First Effective Time automatically
vested in full accelerated in accordance with its terms and was converted into the right to receive, for each share of NV5 Common Stock
represented thereby, the right to receive the Per Share Merger Consideration, less applicable tax withholdings.
The issuance of Acuren
Common Stock in connection with the Merger was registered under the Securities Act of 1933, as amended, pursuant to Acuren’s
registration statement on Form S-4 (File No. 333-287888) (the “Registration Statement”), declared effective by the U.S. Securities
and Exchange Commission (the “SEC”) on June 27, 2025. The joint proxy statement/prospectus, dated July 1, 2025, included in
the Registration Statement contains additional information about the Merger (the “Joint Proxy Statement/Prospectus”).
The foregoing description
of the Merger is not complete and is qualified in its entirety by reference to the copy of the Merger Agreement attached hereto as Exhibit
2.1, which is incorporated herein by reference.
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item 2.03.
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01
is incorporated by reference into this Item 2.03.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
New Directors
In connection with the Merger and pursuant to the
terms of the Merger Agreement, Acuren increased the size of its Board of Directors (the “Board”) at the effective time of
the Second Merger (the “Second Effective Time”) from eight members to eleven members and appointed Dickerson Wright,
Benjamin Heraud and Byron Roth (collectively, the “New Directors”) to the Board, effective as of the Second Effective Time.
The New Directors have not been appointed to serve on a Board committee at this time. The Board has determined that other than Ben Heraud,
each of the New Directors is “independent” within the meaning of NYSE rules.
Other than the Merger Agreement, there are no arrangements
or understandings between the New Directors and any other person pursuant to which they were selected as directors. The New Directors
do not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation
S-K promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Other than Ben Heraud, the New Directors will receive
compensation for their service as directors in accordance with the policies and procedures previously approved by the Board for independent
directors of Acuren, as more fully described in Acuren’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024
under the heading “Director Compensation”. The annual cash retainer for each of Messrs. Dickerson and Roth will
be prorated for 2025 to reflect the effective date of their appointment and each will also receive an annual restricted stock grant, in accordance with the terms of Acuren’s 2024 Equity Incentive Plan.
In connection with the foregoing appointments,
Acuren has entered into its standard form of indemnification agreement with each of the New Directors.
Appointment of President and Chief Operating Officer
In connection with the Merger, on the Closing Date,
Ben Heraud was appointed as President and Chief Operating Officer of Acuren.
Mr. Heraud, age 43, was appointed Chief Executive
Officer of NV5 on January 6, 2025. From March 1, 2024 until January 5, 2025, Mr. Heraud served as the Co-Chief Executive Officer of NV5,
and prior to that he served as Chief Operating Officer for NV5 since May 2017 when he joined NV5 through the acquisition of Energenz.
Mr. Heraud co-founded Energenz in Hong Kong in November 2009 and was the Chief Executive Officer from 2013 through to its acquisition
by NV5. Mr. Heraud has over 20 years of technical experience in the field of energy management consulting, building systems commissioning,
analytics and design oversight. From 2006 to 2009 Mr. Heraud served as Senior Energy Consultant for Energetics in Sydney, Australia. Prior
to this, from 2003 to 2006, he served as Energy and Design Engineer for Spotless Services in Wellington, New Zealand. Mr. Heraud earned
a Bachelor of Science degree in Energy Management from Otago University.
Mr. Heraud did not enter into an employment agreement
with Acuren in connection with his appointment as President and Chief Operating Officer. In connection with his appointment, the Compensation
Committee approved the following compensation for Mr. Heraud: (i) a base salary of $556,000 and (ii) a one-time grant of restricted stock units of Acuren with a fair value of $750,000 to consist of
(x) 50% time-based restricted stock units which will vest on September 30, 2028, and (y) 50% performance-based restricted stock units
which will vest on September 30, 2026 if NV5 achieves its full year 2025 adjusted EBITDA target, in each case subject to the terms and
conditions of Acuren’s form RSU award agreement and Acuren’s 2024 Equity Incentive Plan.
Other than the Merger Agreement, there are no arrangements
or understandings between Mr. Heraud and any other person pursuant to which he was selected as President and Chief Operating Officer.
Mr. Heraud does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a)
of Regulation S-K promulgated under the Exchange Act.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01
Regulation FD
Acuren issued a press
release on August 4, 2025, announcing the closing of the Merger, which is furnished hereto as Exhibit 99.1 and incorporated into this
Item 7.01 by reference.